$ACRX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$ACRX Up to date company activities and other important information about $ACRX

$ACRX

DD Notes ~ http://www.ddnotesmaker.com/ACRX

##### recent news/filings ~ source: finance.yahoo.com

Mon, 07 Jul 2014 14:13:19 GMT ~ AcelRx's Upcoming PDUFA And Trade Recommendations
read full: http://seekingalpha.com/article/2301885-acelr...urce=yahoo
*********************************************************

Mon, 07 Jul 2014 07:00:00 GMT ~ AcelRx and Grunenthal Announce Submission of European Marketing Authorization Application for ZALVISO™
- REDWOOD CITY, Calif. and AACHEN, Germany, July 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX) and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO™ for the management of moderate to severe acute pain in adult patients in a medically supervised environment. ZALVISOTM is a drug-device combination product utilizing the opioid agonist sufentanil formulated in a proprietary sublingual tablet formulation and delivered through a pre-programmed, non-invasive proprietary delivery device. AcelRx and Grunenthal entered into license and supply agreements for ZALVISOTM in the EU, Australia and certain other countries in December 2013. After approval by EMA, AcelRx is eligible to receive approximately $200 million in additional milestone payments, based upon successful regulatory and product development efforts and net sales target achievements. Grunenthal will also make tiered royalty, supply and trademark fee payments in the mid-teens up to the twenty percent range, on net sales of ZALVISOTM in the Grunenthal territory.
read full: http://finance.yahoo.com/news/acelrx-grunenth...00533.html
*********************************************************

Mon, 07 Jul 2014 06:29:00 GMT ~ 2:29 am AcelRx and Grunenthal announce submission of European Marketing Authorization Application for ZALVISO
read full: http://finance.yahoo.com/news/inplay-briefing....html#acrx
*********************************************************

Wed, 02 Jul 2014 12:30:11 GMT ~ AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month
read full: http://seekingalpha.com/article/2296285-acelr...urce=yahoo
*********************************************************

Thu, 19 Jun 2014 11:00:00 GMT ~ AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference
- REDWOOD CITY, Calif., June 19, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 25th. Presentation details are as follows: AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso™, is designed to improve the management of moderate-to-severe acute pain in adult patients in the hospital setting by utilizing a high therapeutic index opioid, through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. AcelRx has announced positive results from each of the three completed Phase 3 clinical trials for Zalviso, and has submitted an NDA to the FDA seeking approval for Zalviso in the treatment of moderate-to-severe acute pain in adult patients in the hospital setting. AcelRx plans to initiate a Phase 3 clinical trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, during the second half of 2014. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.
read full: http://finance.yahoo.com/news/acelrx-pharmace...00958.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=ACRX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=ACRX&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ACRX/company-info
Ticker: $ACRX
OTC Market Place: Not Available
CIK code: not found
Company name: AcelRx Pharmaceuticals, Inc.
Incorporated In:

##### extra dd links

Latest filings: http://www.otcmarkets.com/stock/ACRX/filings
Latest financials: http://www.otcmarkets.com/stock/ACRX/financials
Latest news: http://www.otcmarkets.com/stock/ACRX/news - http://finance.yahoo.com/q/h?s=ACRX+Headlines

Major holdings: http://data.cnbc.com/quotes/ACRX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ACRX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ACRX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ACRX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=AcelRx+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

Short Sales: http://www.otcmarkets.com/stock/ACRX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ACRX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ACRX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ACRX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ACRX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ACRX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ACRX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ACRX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ACRX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ACRX
Balance Sheet: http://finance.yahoo.com/q/bs?s=ACRX
Cash Flow: http://finance.yahoo.com/q/cf?s=ACRX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ACRX
Bloomberg: http://www.bloomberg.com/quote/ACRX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ACRX
Bussinessweek: http://investing.businessweek.com/research/st...icker=ACRX
Barchart: http://www.barchart.com/quotes/stocks/ACRX
OTC Short Report: http://otcshortreport.com/index.php?index=ACRX
Investopedia: http://www.investopedia.com/markets/stocks/ACRX/?wa=0

http://www.pennystocktweets.com/stocks/profile/ACRX

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/ACRX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

La Compagnie Unveils NYC-Düsseldorf Flight Plans

Updated Category News Views 2

A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...

Continue Reading
Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 0

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
Beazer Homes Sale Scrutinized for Shareholder Impact

Updated Category News Views 1

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 3

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Navimow Powers TOP 14 with Tech: A Winning Play

Updated Category News Views 4

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Continue Reading
Reliable Safety & Flow: A New Era in Infrastructure

Updated Category News Views 1

Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 7

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

Updated Category News Views 1

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

Continue Reading
Wooree Group Pushes for Rigorous Liposome Standards

Updated Category News Views 0

Rallying for Rigorous Scientific Validation Ever find yourself pondering how many so-called 'innovative' health products really deliver what they promise? Let me tell ya, Wooree Group’s CEO, Ji-yong Yoon, ain’t buying into flimsy claims. At the Vitafoods Asia 2026 event in Bangkok, Yoon sent a clear message: Without scientific validation, calling a product 'liposomal'...

Continue Reading
Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 1

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading

Top 5 Most Recently Viewed Articles

Yi Shi Celebrates Charity Lunch Win with Marc Benioff at GLIDE

Updated Category News Views 155

Yi Shi's Remarkable Achievement with Marc Benioff Yi Shi, the visionary Founder and CEO of FlashIntel, has recently triumphed in a remarkable charity lunch auction alongside Marc Benioff, the esteemed Chair and CEO of Salesforce. This event is part of the annual GLIDE Power of One Charity Lunch, which aims to generate crucial support for combating social issues like...

Continue Reading
Renaissance Technologies Expands Portfolio with Key Moves in 2024

Updated Category News Views 303

Renaissance Technologies: A Legacy of Success Renaissance Technologies has established itself as a titan in the hedge fund industry. Known for its impressive track record, the firm's Medallion Fund has achieved astonishing annualized returns of 39% from 1998 to 2021. Despite the passing of its legendary founder Jim Simons, the firm continues to make waves in the...

Continue Reading
Paragon 28 Reveals Strong Preliminary Revenue for 2024

Updated Category News Views 255

Paragon 28 Reports Preliminary Revenue Growth for 2024 Paragon 28, Inc. (NYSE: FNA), a prominent player in the medical device industry, has announced its preliminary unaudited revenue figures for the fourth quarter and the entire fiscal year ending in 2024. With its focus solely on the foot and ankle orthopedic market, Paragon 28 continues to demonstrate impressive growth...

Continue Reading
Palvella Therapeutics Embraces Growth with Q3 2025 Results

Updated Category News Views 151

Palvella Therapeutics Celebrates Third Quarter Success Palvella Therapeutics, Inc. (NASDAQ: PVLA) continues to pave the way in rare disease treatment with its QTORIN™-derived product candidates, addressing four serious skin disorders with no FDA-approved therapies available. This is a significant leap forward in providing hope to patients suffering from these...

Continue Reading
Crédit Agricole Assurances' Upcoming Notes Redemption Explained

Updated Category News Views 170

Crédit Agricole Assurances Announces Note Redemption Crédit Agricole Assurances S.A. has made a significant announcement regarding its Undated Subordinated Resettable Notes issued end January 2015. This decision marks an essential step in the company’s ongoing strategy to manage its financial resources effectively. Details of the Redemption The company has confirmed...

Continue Reading